Sophie Michalak
Overview
Explore the profile of Sophie Michalak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
1555
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeng Q, Klein C, Caruso S, Maille P, Allende D, Minguez B, et al.
Lancet Oncol
. 2023 Nov;
24(12):1411-1422.
PMID: 37951222
Background: Clinical benefits of atezolizumab plus bevacizumab (atezolizumab-bevacizumab) are observed only in a subset of patients with hepatocellular carcinoma and the development of biomarkers is needed to improve therapeutic strategies....
2.
Associations between perfluoroalkyl substances and the severity of non-alcoholic fatty liver disease
David N, Antignac J, Roux M, Marchand P, Michalak S, Oberti F, et al.
Environ Int
. 2023 Sep;
180:108235.
PMID: 37776622
Background: Non-alcoholic fatty liver disease (NAFLD) has become the leading cause of chronic liver disease worldwide and the determinants driving its severity remain to be elucidated. Perfluoroalkyl substances (PFAS) are...
3.
Sourty B, Basset L, Michalak S, Colin E, Zidane-Marinnes M, Delion M, et al.
Ann Pathol
. 2023 Aug;
43(6):462-474.
PMID: 37635016
Introduction: Infant-type hemispheric gliomas belong to pediatric-type diffuse high-grade gliomas according to the 2021 WHO classification of central nervous system tumors. They are characterized by tyrosine kinase gene rearrangements (NTRK1/2/3,...
4.
Boursier J, Roux M, Costentin C, Chaigneau J, Fournier-Poizat C, Trylesinski A, et al.
Nat Commun
. 2023 Aug;
14(1):5219.
PMID: 37633932
Unlike for advanced liver fibrosis, the practical rules for the early non-invasive diagnosis of cirrhosis in NAFLD remain not well defined. Here, we report the derivation and validation of a...
5.
Chalin A, Turlin B, Ousmen A, Michalak S, Mueller J, Mueller S, et al.
Aliment Pharmacol Ther
. 2023 Apr;
58(1):80-88.
PMID: 37078366
Background And Aims: The diagnosis of alcoholic steatohepatitis (ASH) is based on liver biopsy, which is costly and invasive with non-negligible morbidity. The aim of this study was to evaluate...
6.
Paisant A, Boursier J, Dabli D, Lebigot J, Oberti F, Michalak S, et al.
J Clin Med
. 2022 Jul;
11(15).
PMID: 35893371
Screening programmes for cirrhotic patients are based on ultrasound (US) examinations at 6-month intervals, but a US sensitivity of 47% has recently been reported. The aim of this study was...
7.
Boursier J, Canivet C, Costentin C, Lannes A, Delamarre A, Sturm N, et al.
Clin Gastroenterol Hepatol
. 2022 Mar;
21(5):1243-1251.e12.
PMID: 35288342
Background & Aims: Noninvasive tests (NITs) of liver fibrosis have been suggested to be less accurate in type 2 diabetes mellitus (T2DM). We aimed to compare the accuracy of 6...
8.
Tauziede-Espariat A, Siegfried A, Nicaise Y, Kergrohen T, Sievers P, Vasiljevic A, et al.
Acta Neuropathol Commun
. 2021 Aug;
9(1):135.
PMID: 34389065
The cIMPACT-NOW Update 7 has replaced the WHO nosology of "ependymoma, RELA fusion positive" by "Supratentorial-ependymoma, C11orf95-fusion positive". This modification reinforces the idea that supratentorial-ependymomas exhibiting fusion that implicates the...
9.
Paisant A, Bellal S, Lebigot J, Canivet C, Michalak S, Aube C
Hepatology
. 2021 Jun;
74(5):2894-2896.
PMID: 34131938
No abstract available.
10.
Legros L, Bardou-Jacquet E, Turlin B, Michalak S, Hamonic S, Le Gruyer A, et al.
Clin Gastroenterol Hepatol
. 2021 Feb;
20(7):1542-1552.e6.
PMID: 33588101
Background & Aims: Liver stiffness measurement by transient elastography (TE) is a promising method for staging fibrosis in alcohol-related liver disease, but uncertainties remain regarding the influence of alcohol consumption...